![](/img/cover-not-exists.png)
LBA7_PRMaintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial
Moore, K N, Colombo, N, Scambia, G, Kim, B-G, Oaknin, A, Friedlander, M, Lisyanskaya, A, Floquet, A, Leary, A, Sonke, G S, Gourley, C, Banerjee, S, Oza, A M, González-Martín, A, Aghajanian, C, BradleyVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.041
Date:
October, 2018
File:
PDF, 107 KB
english, 2018